Volume 72, Issue 3, Pages (August 2007)

Slides:



Advertisements
Similar presentations
Volume 72, Issue 7, Pages (October 2007)
Advertisements

Volume 60, Issue 3, Pages (September 2001)
Volume 64, Issue 6, Pages (December 2003)
Volume 80, Issue 7, Pages (October 2011)
Osteopontin expression in human crescentic glomerulonephritis
Volume 68, Issue 2, Pages (August 2005)
Paraneoplastic glomerulopathies: New insights into an old entity
Podocyte involvement in human immune crescentic glomerulonephritis
Volume 85, Issue 4, Pages (April 2014)
Volume 80, Issue 12, Pages (December 2011)
Volume 62, Issue 6, Pages (December 2002)
Volume 58, Issue 3, Pages (September 2000)
Volume 58, Issue 1, Pages (July 2000)
Volume 72, Issue 6, Pages (September 2007)
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Volume 76, Issue 5, Pages (September 2009)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 69, Issue 10, Pages (May 2006)
Respiratory syncytial virus nephropathy in rats
Volume 60, Issue 2, Pages (August 2001)
Volume 54, Issue 6, Pages (January 1998)
Volume 85, Issue 2, Pages (January 2014)
Glomerular disease related to anti-VEGF therapy
Volume 75, Issue 10, Pages (May 2009)
Patricia L. St. John, Dale R. Abrahamson  Kidney International 
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Volume 63, Issue 1, Pages (January 2003)
Volume 59, Issue 1, Pages (January 2001)
Volume 77, Issue 11, Pages (June 2010)
Volume 60, Issue 3, Pages (September 2001)
Volume 79, Issue 6, Pages (March 2011)
Volume 56, Issue 3, Pages (September 1999)
A new mouse model of immune-mediated podocyte injury
Volume 73, Issue 8, Pages (April 2008)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 88, Issue 5, Pages (November 2015)
Volume 60, Issue 3, Pages (September 2001)
Volume 70, Issue 8, Pages (October 2006)
Volume 71, Issue 1, Pages (January 2007)
Volume 63, Issue 4, Pages (April 2003)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Dysproteinemia, proteinuria, and glomerulonephritis
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 70, Issue 7, Pages (October 2006)
Volume 74, Issue 5, Pages (September 2008)
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Volume 70, Issue 2, Pages (July 2006)
Volume 70, Issue 11, Pages (December 2006)
S.H. Nasr, D.C. Preddie, G.S. Markowitz, G.B. Appel, V.D. D'Agati 
Volume 67, Issue 4, Pages (April 2005)
Local macrophage proliferation in human glomerulonephritis
Volume 68, Issue 4, Pages (October 2005)
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 61, Issue 6, Pages (June 2002)
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene  C.K. Abrass, A.K. Berfield, M.C.
Volume 71, Issue 7, Pages (April 2007)
Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama 
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 72, Issue 7, Pages (October 2007)
Volume 69, Issue 11, Pages (June 2006)
Volume 69, Issue 7, Pages (April 2006)
Volume 70, Issue 2, Pages (July 2006)
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 72, Issue 4, Pages (August 2007)
Volume 63, Issue 1, Pages (January 2003)
Volume 71, Issue 8, Pages (April 2007)
Volume 58, Issue 1, Pages (July 2000)
Volume 68, Issue 1, Pages (July 2005)
Volume 56, Issue 6, Pages (December 1999)
Presentation transcript:

Volume 72, Issue 3, Pages 337-347 (August 2007) Early changes in gene expression that influence the course of primary glomerular disease  L.C. Clement, G. Liu, I. Perez-Torres, Y.S. Kanwar, C. Avila-Casado, S.S. Chugh  Kidney International  Volume 72, Issue 3, Pages 337-347 (August 2007) DOI: 10.1038/sj.ki.5002302 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Induction of proteinuria in the PAN, PHN, and PAN+PHN combination models. (a) PAN and (b) PHN rats develop proteinuria on day 5 (occasionally on day 4), whereas (c) PAN+PHN combination rats become proteinuric on day 2. P<0.001 for all proteinuric time points vs controls in a–c. (d, e) Effect of corticosteroids therapy on proteinuria in (d) PAN and (e) PAN+PHN combination rats is shown. Rats were treated on alternate days with corticosteroids (see text), resulting in mild decrease in proteinuria. (n=4 rats/group in all experiments). x indicates P<0.001; xx indicates P<0.01. Kidney International 2007 72, 337-347DOI: (10.1038/sj.ki.5002302) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Morphological changes in glomeruli in the PAN+PHN combination study on day 6. (a) A control group rat with normal glomerular morphology on periodic acid-Schiff staining is shown. (b) A periodic acid-Schiff-stained glomerulus from the study group with segmental collapse of the capillary loops and some nucleated cells that are either adherent to the glomerular tuft (arrow) or free in the urinary space (arrowhead) are shown. (c) A confocal image showing global collapse of glomerular capillary loops stained with anti-laminin antibody (red). Nuclei are stained with Sytox green. (d) PCNA staining (brown) with hematoxylin counterstain in the PAN+PHN group is shown. The glomerulus has segmental collapse and PCNA-positive cells adherent to the glomerular tuft (arrow) and free in the urinary space (arrowhead). The asterisk indicates a dividing podocyte nucleus, or two very closely placed PCNA-positive cells. Some PCNA-positive cells are also noted in the parietal capsule and the interstitium. Control immunostains were negative and are not shown. Original magnification × 400–1000 (for additional images, see Figure S7). Kidney International 2007 72, 337-347DOI: (10.1038/sj.ki.5002302) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Electron microscopy of PAN, PHN, and PAN+PHN combination injected rats. Podocyte foot processes were preserved on day 3 (a) PAN and (b) PHN, and day 1.5 of (c) the PAN+PHN combination. Effacement of foot processes was noted on day 6 (d) PAN and (e) PHN, and on day 3 (f) PAN+PHN combination. Subepithelial electron-dense deposits (see arrows), a classic feature of PHN, were also noted in the PAN+PHN combination. Original magnification × 10 000–20 000. Kidney International 2007 72, 337-347DOI: (10.1038/sj.ki.5002302) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 Confocal assessment of changes in glomerular protein expression in the PAN+PHN study on day 6. (a–c) Low power images showing absence of albumin staining in the control group, and the presence of albumin (red in B) and neph1 (red in C, arrow) in tubular casts in the study group. In (d–l), green color identifies nuclei. (d–f) Decrease in β2γ1-laminim staining (red) in the (e) noncollapsed and (f) collapsed glomerular capillary loops is shown. Some laminin is also present in the tubular luminal casts (arrow in f), suggesting breakdown of the glomerular capillary loop in the study group. (g–l) Severe depletion of WT1 (blue) and GLEPP1 (red) in glomeruli with collapsed loops, and mild (for WT1) and moderate (for GLEPP1) decrease in glomeruli with preserved capillary loops in the study group, is shown. Green color identifies all nuclei. Control immunostains using preimmune serum or normal IgG were negative and are not shown. Original magnification × 100–400. Kidney International 2007 72, 337-347DOI: (10.1038/sj.ki.5002302) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 Confocal assessment of expression of ZHX proteins in the PAN+PHN combination model. Overall expression of podocyte ZHX1 (green in d, g) and ZHX2 (green in e, h) appears to be decreased in the study group compared to controls (a, b). However, prominent redistribution of ZHX1 and ZHX2 into the nucleus (arrows in d, e, g, h) is noted as early as day 1.5. Because nuclear ZHX proteins are transcriptionally active, it is possible that some of the gene expression changes noted in the combination model, including downregulation of WT1, may be mediated by this early nuclear redistribution of ZHX proteins. The overall expression of ZHX3 appears to be marginally increased (f, i), but prominent redistribution into the nucleus, as published previously in PAN (c), is not obvious. Blue stain identifies all nuclei. Control immunostains using preimmune serum or normal IgG were negative and are not shown. Original magnification × 400. Kidney International 2007 72, 337-347DOI: (10.1038/sj.ki.5002302) Copyright © 2007 International Society of Nephrology Terms and Conditions